rtsst-1v
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02340338)
Timeline
Indications
Studied for
Mechanism of action
- StaphylococcusImmunity, active
Staphylococcus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rtsst-1v
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02814708 | Phase 2 | May 1, 2016 | Biomedizinische Forschungs gmbH, University of Vienna |
| NCT02971670 | Phase 1 | Oct 1, 2015 | Biomedizinische Forschungs gmbH, University of Vienna |
| NCT02340338 | Phase 1 | Jul 1, 2014 | Biomedizinische Forschungs gmbH, University of Vienna |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomedizinische Forschungs gmbH | Academic/Hospital | 3 | 3 | 2 | 2014 |
| University of Vienna | Academic/Hospital | 3 | 0 | 2 | 2014 |
2 organizations
Page 1 / 1